Cheryl L. Ashorn

Cheryl L. Ashorn

Auto-generated profile, based on publicly available information

Cheryl L. Ashorn

Department of Experimental Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2009 in Head & Neck
Verified
Journal Article
Closed access
PDF file
LRLatha Ramdas
Latha Ramdas
UGUma Giri
Uma Giri
CACheryl L. Ashorn
Cheryl L. Ashorn
KCKevin R. Coombes
Kevin R. Coombes
AEAdel El‐Naggar
Adel El‐Naggar
MSMichael Story
Michael Story

1 March 2007 in Cell
Verified
Journal Article
Closed access
RWRuoning Wang
Ruoning Wang
GHGuangan He
Guangan He
MNMayra Nelman-Gonzalez
Mayra Nelman-Gonzalez
CACheryl L. Ashorn
Cheryl L. Ashorn
GGGary E. Gallick
Gary E. Gallick
JKJian Kuang
Jian Kuang

1 February 1994 in Molecular Biology of the Cell
Verified
Journal Article
Open access
PDF file
JKJ Kuang
J Kuang
CAC L Ashorn
C L Ashorn
MGM Gonzalez-Kuyvenhoven
M Gonzalez-Kuyvenhoven
JPJ E Penkala
J E Penkala
MPM-2 antigens, a discrete set of phosphoproteins that contain similar phosphoepitopes recognized by the monoclonal antibody MPM-2, are phosphorylated during M-phase induction. Our previous studies suggested that certain MPM-2 antigens are involved in the appearance of maturation-promoting factor (MPF) activity. Because the central mitotic regulator cdc2 kinase has been shown to exhibit MPF activity, we explored the possibility that certain MPM-2 antigens are regulators of cdc2 kinase. We found that MPM-2 binding of its antigens would inhibit the autoamplification of cdc2 kinase in Xenopus oocytes and interfere with cyclin-activation of cdc2 kinase in Xenopus interphase egg extract. Immunodepletion of MPM-2 antigens from cyclin-induced M-phase egg extract caused the inactivation of cdc2 kinase, which was accompanied by an inhibitory phosphorylation of p34cdc2 on Thr 14 and Tyr 15, indicating that at least one MPM-2 antigen is a positive regulator of p34cdc2 dephosphorylation. We then showed that cdc25 from M-phase arrested egg extract is an MPM-2 antigen. These results suggest that phosphorylation of the epitope recognized by MPM-2 may be a crucial event in the activation of cdc25 and that the kinase(s) that phosphorylates this MPM-2 epitope may be an important regulator of cdc2 kinase activation.

15 November 1993 in Journal of Cell Biology
Verified
Journal Article
Open access
JKJ Kuang
J Kuang
CAC L Ashorn
C L Ashorn
MPM-2 antigens, a discrete set of phosphoproteins that contain similar phosphoepitopes (the MPM-2 epitope), are associated with various mitotically important structures. The central mitotic regulator cdc2 kinase has been proposed to induce M-phase by phosphorylating many proteins which might include the MPM-2 antigens. To clarify the relationship of cdc2 kinase and the MPM-2 antigens, we developed an in vitro assay that enabled us to specifically detect the kinases that phosphorylate the MPM-2 epitope (ME kinases) in crude cell extracts. Two different ME kinase activities were identified in unfertilized Xenopus eggs, neither of which was cdc2 kinase, but both appeared to be activated by the introduction of cdc2 kinase into oocytes or oocyte extract. The two ME kinases differed in molecular size, substrate specificity, peptide components, and MPM-2 reactivity. The larger one, ME kinase-H, phosphorylated several MPM-2 antigens, while the smaller one, ME kinase-L, phosphorylated mainly one. We purified ME kinase-L to near homogeneity by sequential chromatography and showed that it has the characteristics of the 42-kD microtubule-associated protein (MAP) kinase. Our results support the previous finding that MAP kinase is activated during Xenopus oocyte maturation and suggest that MAP kinase may contribute to oocyte maturation induction by phosphorylating one subtype of MPM-2 epitope.

1 December 2000 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
PBPenelope E. Bonnen
Penelope E. Bonnen
MSMichael D. Story
Michael D. Story
CACheryl L. Ashorn
Cheryl L. Ashorn
TBThomas A. Buchholz
Thomas A. Buchholz
MWMichael M. Weil
Michael M. Weil
DNDavid L. Nelson
David L. Nelson

26 February 2004 in Cancer
Verified
Journal Article
Closed access
PDF file
TBThomas Buchholz
Thomas Buchholz
MWMichael M. Weil
Michael M. Weil
CACheryl L. Ashorn
Cheryl L. Ashorn
ESEric Strom
Eric Strom
ASAlice Sigurdson
Alice Sigurdson
MSMichael Story
Michael Story